Bicycle Therapeutics (BCYC) COO sells 1,412 shares in tax-related trades
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bicycle Therapeutics Chief Operating Officer Jennifer Scott Perry reported selling a total of 1,412 Ordinary Shares in open-market transactions on July 2 and July 6, 2026 at prices reported between $4.27 and $4.34 per share. According to the disclosure, these shares were sold to cover statutory tax withholding obligations arising from the vesting and settlement of RSUs under a mandated “sell to cover” arrangement, rather than as discretionary sales. The transactions were carried out under a Rule 10b5-1 trading plan adopted on March 27, 2025, and Perry continues to hold approximately 91,052 Ordinary Shares directly after the reported sales.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 1,412 shares ($6,054)
Net Sell
3 txns
Insider
Perry Jennifer Scott
Role
Chief Operating Officer
Sold
1,412 shs ($6K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 43 | $4.31 | $185.33 |
| Sale | Ordinary Shares | 333 | $4.34 | $1K |
| Sale | Ordinary Shares | 1,036 | $4.27 | $4K |
Holdings After Transaction:
Ordinary Shares — 91,385 shares (Direct, null)
Footnotes (1)
- Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.
Key Figures
Total shares sold: 1,412 shares
Sale prices: $4.27–$4.34 per share
Shares held after transactions: 91,052 shares
+2 more
5 metrics
Total shares sold
1,412 shares
Open-market sales on July 2 and 6, 2026
Sale prices
$4.27–$4.34 per share
Reported transaction prices for Ordinary Shares
Shares held after transactions
91,052 shares
Direct ownership following final reported sale
Largest single sale
1,036 shares
Ordinary Shares sold on July 2, 2026 at $4.27
Trading plan adoption date
March 27, 2025
Rule 10b5-1 plan covering these transactions
Key Terms
RSUs, statutory tax withholding obligations, sell to cover, Rule 10b5-1 trading plan, +1 more
5 terms
RSUs financial
"in connection with the vesting and settlement of the RSUs."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
statutory tax withholding obligations financial
"shares required to be sold to cover the statutory tax withholding obligations"
sell to cover financial
"funded by a "sell to cover" transaction and does not represent a discretionary sale"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Rule 10b5-1 trading plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What did Bicycle Therapeutics (BCYC) disclose in this Form 4 filing?
Bicycle Therapeutics reported that COO Jennifer Scott Perry sold 1,412 Ordinary Shares. The sales were primarily to cover statutory tax withholding obligations tied to RSU vesting and occurred under a pre-arranged Rule 10b5-1 trading plan adopted in March 2025.